Evidence map›Paper›PMID 36426845›Full record

ArticleInflammatory bowel diseases2023

Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases.

Catherine Robbe Masselot, Camille Cordier, Benjamin Marsac, Maria Nachury, Renaud Léonard, Boualem Sendid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inflammatory bowel diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A preliminary study of HMGB1 defense in Crohn's disease.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Catherine Robbe MasselotUnité de Glycobiologie Structurale et Fonctionnelle (CNRS UMR 8576), Université de Lille, Lille, France.
Camille CordierLaboratoire de Parasitologie-Mycologie, INSERM U1285, Unité de Glycobiologie Structurale et Fonctionnelle (CNRS UMR 8576), Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France.
Benjamin MarsacUnité de Glycobiologie Structurale et Fonctionnelle (CNRS UMR 8576), Université de Lille, Lille, France.
Maria NachuryINSERM U1286, Institute for Translational Research in Inflammation, Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France.
Renaud LéonardUnité de Glycobiologie Structurale et Fonctionnelle (CNRS UMR 8576), Université de Lille, Lille, France.
Boualem SendidLaboratoire de Parasitologie-Mycologie, INSERM U1285, Unité de Glycobiologie Structurale et Fonctionnelle (CNRS UMR 8576), Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France.ORCID 0000-0003-1577-7325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Inflammatory Bowel DiseasesMucinsBiomarkersGlycosylationHumansBiomarkersMucinsCrohn’s diseasediagnosishuman stoolsinflammatory bowel syndromemucin glycans

Identifiers

PMID36426845
PMCPMC9825277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.